Startup profile for Vanna Health: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Vanna Health funding, valuation and investors

Value-based technology-enabled care for serious mental illness (schizophrenia, bipolar).

Keep track of Vanna Health

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$17M · June 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$17M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · San Francisco, CA

Investors in latest funding

Lead: AlleyCorp

Sources: latest funding Last verified: 2026-07-25

Overview

Vanna Health delivers integrated, community-based care for people living with serious mental illness including schizophrenia, schizoaffective disorder, and bipolar disorder. Founded with involvement from Dr. Tom Insel (former NIMH director), Vanna raised $17M in June 2026 co-led by AlleyCorp and a national health insurer with Health Velocity Capital participating — following an earlier ~$29M Series A in 2022.

Why Vanna Health is interesting

SMI care fails on fragmentation — Vanna combines clinical teams, coaches, and physical community sites under value-based contracts reducing systemic cost.

Product & use cases

Tech-enabled care model integrating medical professionals, peer coaches, and community locations emphasizing people, place, and purpose.

  • Community-based SMI treatment programs
  • Payer value-based contracts reducing hospitalizations
  • Coordinated medical and psychosocial support

Key facts

  • Series B (Jun 2026): $17M co-led by AlleyCorp + national insurer
  • Prior Series A ~$29M (2022)
  • Founder lineage includes Dr. Tom Insel
  • Value-based SMI care model

Funding history (newest first)

Investors in our directory

Funds linked from Vanna Health's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: AlleyCorp healthcare vertical backing plus national insurer co-lead validating payer economics.

SMI requires trust and continuity — technology alone fails. Vanna's model is operationally heavy; expansion depends on payer contracts and clinician supply.

  • Legacy community mental health centers incumbent

    Underfunded public systems.

  • Telepsychiatry-only startups adjacent

    Virtual care without community placement.

  • Academic SMI clinics incumbent

    Specialized but capacity constrained.

Notable stories

  • Behavioral Health Business noted Vanna's three principles: people, place, purpose for SMI recovery.

Industries

Healthtech

Related funding articles

Venture Capital Tracker pieces that cover Vanna Health's financing or category context.

FAQs about Vanna Health

Practical answers founders, operators, and investors typically search for.

Technology-enabled community care for serious mental illness.
AlleyCorp co-led $17M round June 2026. See /fund/alleycorp.
$17M Series B.
Schizophrenia, schizoaffective disorder, bipolar disorder.
Dr. Tom Insel among behavioral health leaders associated with founding.
In-person community model plus coaches, not video-only.
Private; value-based contracts aim at systemic savings.
San Francisco per 2026 announcements.
Schizophrenia-spectrum and bipolar disorders requiring intensive support.
~$29M Series A in 2022 before 2026 round.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.